Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis

Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Ling Zhu, Li Zhong, Guidong Huang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185026/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis.
by: Ling Zhu, et al.
Published: (2025-01-01)

Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza
by: Jiali Jiang, et al.
Published: (2025-07-01)

Efficacy of baloxavir marboxil against bovine H5N1 virus in mice
by: Maki Kiso, et al.
Published: (2025-06-01)

Clinical and Virologic Outcomes of Baloxavir Compared with Oseltamivir in Pediatric Patients with Influenza in Japan
by: Nobuhisa Ishiguro, et al.
Published: (2025-03-01)

Validation of chromatographic method for impurity profiling of Baloxavir marboxil (Xofluza)
by: Wang Yiyun, et al.
Published: (2025-03-01)

Safety evaluation of baloxavir marboxil: analysis and discussion utilizing real adverse events from the FAERS database
by: Xiaolong Lai, et al.
Published: (2025-05-01)

Ultrasensitive turn-off fluorescent sensor for estimation of the new influenza antiviral prodrug baloxavir marboxil in its pharmaceutical formulation
by: Amira S. Gouda, et al.
Published: (2025-01-01)

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
by: Jack T Nguyen, et al.
Published: (2012-01-01)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
by: A.S. Darmanyan
Published: (2007-10-01)

Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024
by: Emi Takashita, et al.
Published: (2025-05-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
by: Anthony C Marriott, et al.
Published: (2014-01-01)

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
by: A. V. Averyanov, et al.
Published: (2020-05-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study.
by: Hiroshi Kakeya, et al.
Published: (2014-01-01)

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection
by: Xuhui Liu, et al.
Published: (2013-01-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
by: L. V. Osidak, et al.
Published: (2016-09-01)

Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses
by: C. Joaquín Cáceres, et al.
Published: (2021-01-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
by: T.V. Kulichenko, et al.
Published: (2007-12-01)

Prescription of Antibiotics Among Patients Receiving Oseltamivir with an Influenza Related Diagnosis Over Three Influenza Seasons
by: Mine Durusu Tanriover, et al.
Published: (2024-12-01)

Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
by: Justin D Hoopes, et al.
Published: (2011-01-01)

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19
by: Sara Samir Mohamed Elmenshawy, et al.
Published: (2024-12-01)

Efficacy and safety of Xiao’er Fengre Qing oral liquid versus Oseltamivir in treating pediatric influenza (wind-heat invading the defense syndrome): a multicenter, randomized, non-inferiority trial
by: Shengxuan Guo, et al.
Published: (2025-05-01)

INCREASED ANTI-INFLUENZA EFFICACY OF OSELTAMIVIR (TAMIFLU<sup>®</sup>) AND UMIFENOVIR (ARBIDOL<sup>®</sup>) BY COMBINED USE WITH KAGOCEL<sup>®</sup>
by: A. F. Popov, et al.
Published: (2020-05-01)

Impact of Oseltamivir and Diabetes Development
by: Bor-Show Tzang, et al.
Published: (2025-01-01)

In vitro Investigation of Ingavirin® Efficacy Against Influenza B Virus
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
by: Jeff Butler, et al.
Published: (2014-04-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
by: A.B. Ivanyuk, et al.
Published: (2008-01-01)

Pandemic influenza A(H1N1) 2009 virus outbreak among boarding school pupils in Madagascar: compliance and adverse effects of prophylactic oseltamivir treatment
by: Soatiana Rajatonirina, et al.
Published: (2011-03-01)

Mechanism of action of substituted peramivir phosphonate derivatives as potent oseltamivir-resistant influenza A virus using molecular docking, molecular dynamics simulations, and free energies calculations
by: Emmanuel Israel Edache, et al.
Published: (2025-05-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
by: A.S. Kolbin, et al.
Published: (2008-11-01)

In Silico Profiling of Binding Affinities of Hybrid Molecules of Oseltamivir carboxamides cross-linked with Hydroxamic acid as possible Anti-influenza agents
by: Sumia Samer Tayah, et al.
Published: (2025-05-01)

Evaluation of drug-drug interaction between Suraxavir Marboxil (GP681) and itraconazole, and assessment of the impact of gene polymorphism
by: Mai Han, et al.
Published: (2025-04-01)

Effect of Oseltamivir Use on Follow-Up Stroke Mortality
by: Pei-Hua Chuang, et al.
Published: (2025-05-01)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
by: Elsa Hansen, et al.
Published: (2010-01-01)

Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1)
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Bunyaviral Cap-Snatching Endonuclease Activity and Inhibition with Baloxavir-like Inhibitors in the Context of Full-Length L Proteins
by: Arlo J. Loutan, et al.
Published: (2025-03-01)

Safety of Influenza Vaccines in Children
by: Editorial Article
Published: (2015-12-01)